These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

816 related items for PubMed ID: 15603272

  • 1. [Is there a future for COX-2 inhibitors?].
    Yodfat Y.
    Harefuah; 2004 Nov; 143(11):820-4, 837. PubMed ID: 15603272
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. COX-2 inhibitors.
    Brooks PM, Day RO.
    Med J Aust; 2000 Oct 16; 173(8):433-6. PubMed ID: 11090038
    [Abstract] [Full Text] [Related]

  • 4. [Coxibs: cyclooxygenase-2 inhibitors].
    Turnheim K.
    Wien Klin Wochenschr; 2001 Aug 16; 113(15-16):558-65. PubMed ID: 11571832
    [Abstract] [Full Text] [Related]

  • 5. Comparison of the baseline cardiovascular risk profile among hypertensive patients prescribed COX-2-specific inhibitors or nonspecific NSAIDs: data from real-life practice.
    Zhao SZ, Burke TA, Whelton A, von Allmen H, Henderson SC.
    Am J Manag Care; 2002 Oct 16; 8(15 Suppl):S392-400. PubMed ID: 12416789
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Selective COX-2 inhibition and cardiovascular effects: a review of the rofecoxib development program.
    Weir MR, Sperling RS, Reicin A, Gertz BJ.
    Am Heart J; 2003 Oct 16; 146(4):591-604. PubMed ID: 14564311
    [Abstract] [Full Text] [Related]

  • 8. A regional audit of the use of COX-2 selective non-steroidal anti-inflammatory drugs (NSAIDs) in rheumatology clinics in the West Midlands, in relation to NICE guidelines.
    Price-Forbes AN, Callaghan R, Allen ME, Rowe IF.
    Rheumatology (Oxford); 2005 Jul 16; 44(7):921-4. PubMed ID: 15827035
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Treatment of rheumatoid arthritis and osteoarthritis with COX-2-selective inhibitors: a managed care perspective.
    Hochberg MC.
    Am J Manag Care; 2002 Nov 16; 8(17 Suppl):S502-17. PubMed ID: 12458820
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Osteoarthritis therapy--are there still unmet needs?
    Laufer S.
    Rheumatology (Oxford); 2004 Feb 16; 43 Suppl 1():i9-15. PubMed ID: 14752170
    [Abstract] [Full Text] [Related]

  • 13. Clinical experience with cyclooxygenase-2 inhibitors.
    Lanas A.
    Rheumatology (Oxford); 2002 Apr 16; 41 Supp 1():16-22; discussion 35-42. PubMed ID: 12173276
    [Abstract] [Full Text] [Related]

  • 14. Clinical pharmacology of selective COX-2 inhibitors.
    Capone ML, Tacconelli S, Sciulli MG, Patrignani P.
    Int J Immunopathol Pharmacol; 2003 Apr 16; 16(2 Suppl):49-58. PubMed ID: 14552704
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 41.